Dear MRI Insider,
Can synthetic MRI replace conventional exams for evaluating brain health? A team of researchers from China says yes.
In this edition's Insider Exclusive, we're highlighting findings a team from Gangzhou has reported suggesting that synthetic MRI shows promise for reducing exam times and improving metrics like signal-to-noise ratio and contrast-to-noise ratio.
Once you've read our exclusive, take a look at our recent coverage on a variety of MRI research findings, including a study that outlines how a stroke indicator called percent insular ribbon infarction, or PIRI, could help clinicians tailor treatment; a comparison between photon-counting CT and MRI for assessing hepatic steatosis; and a report that explores why most women with neurofibromatosis type 1 may undergo mammography to track the progress of the disease but seem to skip breast MRI -- even though it is also recommended for this indication.
Then check out our report on how radiomics and artificial intelligence can characterize breast lesions on MRI, and our story on how unnecessary clinical use of MRI can contribute to carbon dioxide emissions -- and what actions could be taken to mitigate this.
Again and again, MRI shows itself to be a powerful and versatile imaging technology in the healthcare toolkit. We invite you to keep current on its many uses by regularly visiting our MRI Community. And if you have MRI topics you'd like us to consider, please contact me.